Piptide Chemotypes for Perturbation of the Interaction of Urokinase with Its Receptor.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
Only a few small molecules that disrupt the uPA and uPA receptor (uPAR) interaction have been discovered despite decades of research in the area, and none have been approved in clinical trials. Research reported here features two new ways of considering the problem of discovering small molecules to disrupt uPAuPAR, specifically in terms of chemotype design and method of evaluation. Chemotypes used in this work are piptides (Arancillo . Angew. Chem., Int. Ed., 2021, 60, 6653-6659) with side chains corresponding to the uPA loop that binds uPAR. Further, hybrids of 1 and another uPAR ligand developed in these labs (2), i.e., 3 and 4, were also designed and tested. All the piptide chemotypes bound uPAR at concentrations of 50 M or less. Members of this series had Ki values <3 M and showed favorable responses in cellular assays; these data are comparable with the best small molecule uPAuPAR disruptors in the literature (from conventional screening).